LTC Properties, Sabra Health Care REIT upgraded at JMP on expected returns
Health Care REITs LTC Properties (NYSE:LTC) and Sabra (NASDAQ:SBRA) were upgraded at JMP, citing multiple tailwinds are expected to result in outsized returns. JMP raised its recommendation on the stocks to Market Outperform from Market Perform.
Why Sabra Health Care REIT Inc (SBRA) Stock is Currently 0.03% Above from Its 20-Day SMA?
JMP Securities has recently raised Sabra Health Care REIT Inc (SBRA) stock to Mkt Outperform rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 5, 2024, Mizuho had reduced the stock from a Outperform to Neutral,
JMP Securities Upgrades Sabra Health Care REIT (SBRA)
Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from Market Perform to Market Outperform. Analyst Price Forecast Suggests 20.32% Upside As of December 23,
Sabra Health Care REIT: Buy Into Future Demand For Skilled Nursing Facilities
Sabra Health Care REIT rated buy, undervalued compared to peers. Investment-grade ratings, +7% dividend yield opportunity. Read more on SBRA stock here.
Sabra Healthcare REIT (SBRA) was upgraded to a Buy Rating at JMP Securities
In a report released today, Aaron Hecht from JMP Securities upgraded Sabra Healthcare REIT (SBRA – Research Report) to a Buy, with a price
Sabra Health Care REIT, Amazon And More: CNBC's 'Final Trades'
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management picked Sabra Health Care REIT, Inc. as her final trade.
Sabra Health Care REIT: A High-Yielding Gift Just In Time For The New Year
Sabra Health Care REIT's balance sheet strengthened, with Moody's upgrading its outlook to positive. Read why SBRA stock is a Buy for long-term investors.
Sabra Health Care upgraded to Outperform from Market Perform at JMP Securities
JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple
Sabra Health Care price target lowered to $20 from $21 at Jefferies
Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part ...
Morningstar6d
Sabra Health Care REIT Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Nasdaq25d
Sabra Health Care REIT, Inc. Common Stock (SBRA) Institutional Holdings
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...